Xenon Pharmaceuticals Inc
NASDAQ:XENE
Xenon Pharmaceuticals Inc
Cash from Investing Activities
Xenon Pharmaceuticals Inc
Cash from Investing Activities Peer Comparison
Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Investing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
X
|
Xenon Pharmaceuticals Inc
NASDAQ:XENE
|
Cash from Investing Activities
-$117.2m
|
CAGR 3-Years
-91%
|
CAGR 5-Years
-32%
|
CAGR 10-Years
N/A
|
Zymeworks Inc
NYSE:ZYME
|
Cash from Investing Activities
-$207.3m
|
CAGR 3-Years
-68%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
N/A
|
|
Repare Therapeutics Inc
NASDAQ:RPTX
|
Cash from Investing Activities
$78m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Fusion Pharmaceuticals Inc
NASDAQ:FUSN
|
Cash from Investing Activities
-$42.8m
|
CAGR 3-Years
41%
|
CAGR 5-Years
-107%
|
CAGR 10-Years
N/A
|
|
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
|
Cash from Investing Activities
-$6.7m
|
CAGR 3-Years
65%
|
CAGR 5-Years
-149%
|
CAGR 10-Years
-67%
|
|
Spectral Medical Inc
TSX:EDT
|
Cash from Investing Activities
-CA$185k
|
CAGR 3-Years
15%
|
CAGR 5-Years
-30%
|
CAGR 10-Years
N/A
|
See Also
What is Xenon Pharmaceuticals Inc's Cash from Investing Activities?
Cash from Investing Activities
-117.2m
USD
Based on the financial report for Dec 31, 2023, Xenon Pharmaceuticals Inc's Cash from Investing Activities amounts to -117.2m USD.
What is Xenon Pharmaceuticals Inc's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 5Y
-32%
Over the last year, the Cash from Investing Activities growth was 60%. The average annual Cash from Investing Activities growth rates for Xenon Pharmaceuticals Inc have been -91% over the past three years , -32% over the past five years .